InvestorsHub Logo

jugygales

04/02/12 7:33 AM

#221 RE: sons4 #220

Thanks for the info sons.

I just wish I would have found this company back in November when it was below $1. But it still looks like it is undervalued and a good buy at these levels.

The other thing I like is that it looks like they can get their products to the market faster than a drug, if everything goes right.

Looks like this is really under the radar. 2012 could be the year when some eyes start looking at NVIV.